Status:

RECRUITING

Treatment of Chronic Anger and Aggression Following Military-Related Betrayal

Lead Sponsor:

The University of Texas Health Science Center at San Antonio

Collaborating Sponsors:

United States Department of Defense

Conditions:

Anger Problems

Aggression

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The goal of this clinical trial is to learn if a treatment designed to deal with anger and aggression from a past betrayal will work. The study will be done on active duty military service members and...

Detailed Description

Participants will undergo the study procedures described below. The preferred method of assessment and treatment is face-to-face in the STRONG STAR offices at Fort Cavazos. However, there may be circu...

Eligibility Criteria

Inclusion

  • Adult active duty military service members and veterans aged 18 or older.
  • Endorses a history of military-related betrayal (on the Modified Moral Injury Questionnaire)
  • Endorses problematic anger in the past month (as evidenced by a score of 12 or above on the Dimensions of Anger Reactions; DAR-5)
  • Engaged in at least 1 self-reported act of aggression in the past 1 month (on the Overt Aggression Scale-Modified; OAS-M)

Exclusion

  • Participated in an anger management or trauma-focused intervention within the past 3 months as assessed by self-report.
  • Acute suicidality requiring immediate intervention, such as hospitalization as assessed by the Depressive Symptoms Index-Suicidality Subscale (DSI-SS) combined with follow up clinical interview for elevated scores.
  • Is currently homicidal with plans and intent to hurt a specific person and requiring immediate intervention as measured by self-report and follow-up with clinician if screened positive.
  • Moderate to severe brain injury as measured by inability to comprehend the informed consent document or baseline assessments.
  • Has severe alcohol consumption patterns as evidenced by a score of 19 or above on the Alcohol Use Disorders Identification Test (AUDIT).
  • Experiencing active psychosis or mania as measured by the Prodromal Questionnaire-Brief Version and the Mood Disorders Questionnaire.

Key Trial Info

Start Date :

March 17 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2026

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT06609330

Start Date

March 17 2025

End Date

December 1 2026

Last Update

March 28 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Carl R. Darnall Army Medical Center (CRDAMC) at Fort Cavazos

Fort Cavazos, Texas, United States, 76554